🕵️ ANI Pharmaceuticals Inc ($ANIP)
SEC insider & ownership activity, last 12 months · CIK 1023024 · every row links its SEC filing
Over the last 12 months insiders sold $15.0M with no open-market buying against it. Nikhil Lalwani sold $5.1M in discretionary trades (May–Sep). 1 planned sale is pending, the largest $374K (Patrick Walsh). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 12 sellers, $15.0M (48 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Nikhil Lalwani | 0 | – | 3 | $5.1M | Sep 15, 2026 |
| Patrick D. Walsh | 0 | – | 4 | $2.3M | May 13, 2026 |
| Stephen P. Carey | 0 | – | 7 | $1.8M | Aug 31, 2026 |
| Mutz Christopher | 0 | – | 6 | $1.6M | Mar 13, 2026 |
| Gassert Chad | 0 | – | 2 | $1.3M | Nov 13, 2025 |
| Davis Krista | 0 | – | 6 | $1.0M | Mar 9, 2026 |
| Gutwerg Ori | 0 | – | 3 | $621K | Aug 10, 2026 |
| Cook Meredith | 0 | – | 12 | $454K | Sep 14, 2026 |
| Rowland Thomas Andrew | 0 | – | 2 | $394K | May 12, 2026 |
| Thomas Haughey | 0 | – | 1 | $162K | Jun 8, 2026 |
| Renee P. Tannenbaum | 0 | – | 1 | $146K | Dec 5, 2025 |
| Thoma Jeanne | 0 | – | 1 | $72K | Sep 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12.8% | 13G | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Nikhil Lalwani | $380K | Sep 15, 2026 | filing ↗ |
| Jeanne Thoma | $71K | Sep 11, 2026 | filing ↗ |
| Nikhil Lalwani | $401K | Aug 25, 2026 | filing ↗ |
| Stephen P. Carey | $499K | Jul 29, 2026 | filing ↗ |
| Patrick Walsh | $374K | Jul 7, 2026 | filing ↗ |
| Thomas Haughey | $162K | Jun 8, 2026 | filing ↗ |
| Stephen P. Carey | $939K | Jun 5, 2026 | filing ↗ |
| Patrick D. Walsh | $796K | May 13, 2026 | filing ↗ |
| Nikhil Lalwani | $4.3M | May 11, 2026 | filing ↗ |
| Patrick Walsh | $321K | May 11, 2026 | filing ↗ |
| Stephen P. Carey | $552K | Mar 5, 2026 | filing ↗ |
| Patrick Walsh | $445K | Mar 3, 2026 | filing ↗ |
| Renate Plawner Tannenbaum 2024 RV Trust | $146K | Dec 5, 2025 | filing ↗ |
| Patrick Walsh | $751K | Nov 13, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Aug 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 19, 2026 | filing ↗ |
| Earnings (2.02) | Aug 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | May 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 8, 2026 | filing ↗ |
| Auditor change (4.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Earnings (2.02) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Nov 24, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 24, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 7, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 26, 2025 | filing ↗ |